Comparison of PENG Block and FICB in Hip Fracture Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-21

Study Completion Date

2022-02-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fascia iliaca compartment block (FICB) has been considered the block of choice for patients with hip fracture. However, pericapsular nerve group (PENG) block, one of the relatively newly-developed blocks, could be also used for analgesia in patients with hip fracture. Since PENG block could block the accessory obturator nerve, PENG block might have greater analgesic effects compared to FICB theoretically. However, the comparison of these two blocks in patients with hip fracture has not performed in clinical setting. Thus, we aimed to compare the analgesic effect of PENG block and FICB.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparing The Effectiveness Of Pericapsular Nerve Group (PENG) Block Versus Supra-Inguinal Fascia Iliaca Compartment Block(S-FICB) In Reducing Positional Pain During Neuraxial Anaesthesia In Hip Fractures Patients

NCT05721924

Hip Fractures

UNKNOWN PHASE4

Efficacy of Pericapsular Nerve Group Block

NCT05154318

Acute Pain

RECRUITING NA

Comparing Fascia Iliaca Compartment Block and Pericapsular Nerve Group Block for Hip Fracture Pain Control

NCT04210700

Hip Fractures Analgesia Nerve Blocks

COMPLETED NA

PENG vs. FIC Blocks in Hip Fractures in the ED

NCT06336460

Hip Fractures Nerve Block Analgesia

NOT_YET_RECRUITING NA

COmparison of PENG Block and SIFICB in Hip Fracture Surgeries

NCT06878963

Hip Fracture Pericapsular Nerve Group Block (PENG Block) Suprainguinal Fasya Iliaca Block

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures Regional Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PENG group

pericapsular nerve group (PENG) block before surgery

Group Type EXPERIMENTAL

Pericapsular nerve group (PENG) block

Intervention Type PROCEDURE

ultrasound-guided PENG block with 0.3% ropivacaine 20cc

FICB group

suprainguinal fascia iliaca compartment block (FICB) before surgery

Group Type ACTIVE_COMPARATOR

Fascia iliaca compartment block (FICB)

Intervention Type PROCEDURE

ultrasound-guided suprainguinal FICB with 0.3% ropivacaine 30cc

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pericapsular nerve group (PENG) block

ultrasound-guided PENG block with 0.3% ropivacaine 20cc

Intervention Type PROCEDURE

Fascia iliaca compartment block (FICB)

ultrasound-guided suprainguinal FICB with 0.3% ropivacaine 30cc

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA PS 1-4
* age: ≥19
* baseline pain score (associated with hip fracture): ≥4

Exclusion Criteria

* patients who do not agree to participate in this study
* patients with uncontrolled hypertension, hyperthyroidism, severe dementia
* allergic to ropivacaine
* contraindicated to spinal anesthesia due to coagulopathy, severe aortic stenosis/mitral stenosis, or active infection on lumbar region
* patients who are considered ineligible with any other reason by investigators

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No